Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review highlights the potential of ridge gourd (Luffa acutangula) in promoting healthy hair growth due to its nutrients and antioxidants, with suggestions of benefits such as follicle strengthening and delaying graying, though it calls for more clinical studies to verify these effects.

Deuruxolitinib effectively promotes hair regrowth in alopecia areata.

This study found that creambath preparations with waru leaf extract accelerated hair growth in New Zealand White rabbits, though none matched the positive control; the 37.5% concentration increased hair weight effectively.

This review discusses the approved uses and adverse reactions of JAK inhibitors, noting their importance in treating various conditions but highlighting significant hematological and immunological risks.

This article describes a case of hypertrichosis potentially induced by using efalizumab but provides no new clinical study results.

This study concluded that a compound formulation was effective in improving various clinical symptoms of dermatophytosis, including itching, scaling, and erythema, after 45 days of treatment.

This study found that Urticadioica L ethanol extracts enhanced hair growth and reduced catagen transition in human hair follicles in an ex vivo organ culture model.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

In this study, patients with mild to moderate scalp seborrheic dermatitis experienced greater improvements in severity scores and quality of life with Lulican™ shampoo compared to Ketoconazole over four weeks, with similar safety profiles but better tolerability and cosmetic acceptability for LulicanTM.

This review discusses the potential role of JAK inhibitors, like ruxolitinib, as emerging therapeutic agents in dermatology, but reports no new clinical results.

This review discusses azelaic acid's mechanisms and uses in dermatology, noting its effectiveness in treating conditions like rosacea, acne, and melasma, but reports no new clinical results.

This study reports that ZD1839 (Iressa), an anticancer drug, was associated with acneiform eruptions and hair growth abnormalities due to its inhibition of epidermal growth factor receptor signaling in the skin.

This study reports that JAK inhibitors were effective in inducing remission in ulcerative colitis patients and presented an acceptable safety profile with a range of manageable side effects.

In this study, a herbal shampoo using bael extract was formulated and found to have good cleansing efficiency and stable properties, suggesting it as a safe and eco-friendly alternative to synthetic shampoos with potential benefits for scalp health.

This article reviews melatonin's roles, including regulating sleep and mitigating oxidative stress, and reports no new research findings.

This study reports that customer satisfaction with Indulekha products largely depends on product quality over cost and emphasizes the need for innovation to maintain market competitiveness.

This study found that red light exposure significantly enhanced the growth, phytochemical content, and therapeutic potential of Eclipta alba callus cultures compared to other multispectral light exposures.

This document promotes a 25% discount code for Soulflower's natural beauty products, detailing the steps for applying the code and highlighting the benefits of their organic skincare and haircare items.

This promotional text about Alpha Xtra Boost does not report any new research findings or clinical results.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

This study reports a case of complete hair regrowth in lichen planopilaris after 12 weeks of treatment with ixekizumab, suggesting its potential as a targeted therapy.

A woman developed lupus after taking hydroxyurea for two years.

In this study, adults with significant alopecia areata were surveyed on their preferences for JAK inhibitor treatments, revealing a strong priority for scalp hair regrowth effectiveness and quicker initial regrowth over dosing convenience.

This study in Mexican adolescents with severe alopecia areata reported that oral tofacitinib treatment resulted in hair growth and reduced alopecia severity without serious adverse effects.

This article details various skin and oral lesions through illustrative figures but does not present new research results.

This study found that clinicians treating alopecia areata prioritize JAK inhibitor treatments with higher efficacy and faster initial hair growth, regardless of dosing frequency, and preferred the treatment option with ritlecitinib 50-mg data the least among several blinded profiles.